Free Trial

K Charles Janac Sells 2,057 Shares of Arteris (NASDAQ:AIP) Stock

Arteris logo with Computer and Technology background

Key Points

  • CEO K Charles Janac sold 2,057 shares of Arteris stock at an average price of $8.73, decreasing his position by 1.09%.
  • Arteris shares dropped 3.0% to $8.59, with a twelve-month low of $5.46 and a high of $14.29, despite the firm reporting revenue of $16.50 million for the previous quarter.
  • Analysts recently downgraded Arteris from a "hold" to a "sell" rating, while others maintained a "buy" rating with a target price of $15.00.
  • Five stocks we like better than Arteris.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) CEO K Charles Janac sold 2,057 shares of the firm's stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $8.73, for a total value of $17,957.61. Following the completion of the sale, the chief executive officer directly owned 186,482 shares of the company's stock, valued at approximately $1,627,987.86. This represents a 1.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

K Charles Janac also recently made the following trade(s):

  • On Tuesday, September 2nd, K Charles Janac sold 1,246 shares of Arteris stock. The stock was sold at an average price of $8.94, for a total value of $11,139.24.
  • On Tuesday, August 5th, K Charles Janac sold 50,000 shares of Arteris stock. The stock was sold at an average price of $13.12, for a total value of $656,000.00.
  • On Tuesday, August 5th, K Charles Janac sold 94,245 shares of Arteris stock. The stock was sold at an average price of $13.49, for a total value of $1,271,365.05.
  • On Thursday, July 3rd, K Charles Janac sold 11,815 shares of Arteris stock. The stock was sold at an average price of $9.25, for a total value of $109,288.75.
  • On Wednesday, July 2nd, K Charles Janac sold 7,153 shares of Arteris stock. The stock was sold at an average price of $8.99, for a total value of $64,305.47.
  • On Tuesday, July 1st, K Charles Janac sold 2,666 shares of Arteris stock. The stock was sold at an average price of $9.09, for a total value of $24,233.94.
  • On Friday, June 27th, K Charles Janac sold 18,620 shares of Arteris stock. The stock was sold at an average price of $10.02, for a total value of $186,572.40.

Arteris Stock Down 3.0%

Shares of Arteris stock traded down $0.27 on Monday, reaching $8.59. 788,912 shares of the stock were exchanged, compared to its average volume of 550,525. Arteris, Inc. has a twelve month low of $5.46 and a twelve month high of $14.29. The firm has a market capitalization of $366.36 million, a price-to-earnings ratio of -10.48 and a beta of 1.44. The business has a 50 day moving average price of $9.52 and a two-hundred day moving average price of $8.22.

Arteris (NASDAQ:AIP - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, hitting analysts' consensus estimates of ($0.11). Arteris had a negative return on equity of 8,546.17% and a negative net margin of 52.41%.The firm had revenue of $16.50 million during the quarter, compared to the consensus estimate of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Research analysts forecast that Arteris, Inc. will post -0.73 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on the company. Wall Street Zen downgraded Arteris from a "hold" rating to a "sell" rating in a report on Sunday. Rosenblatt Securities reissued a "buy" rating and issued a $14.00 price target on shares of Arteris in a report on Wednesday, May 21st. Finally, TD Cowen boosted their price target on Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Three equities research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Arteris presently has a consensus rating of "Buy" and a consensus target price of $15.00.

Read Our Latest Report on AIP

Institutional Trading of Arteris

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Squarepoint Ops LLC increased its position in shares of Arteris by 143.8% in the second quarter. Squarepoint Ops LLC now owns 120,957 shares of the company's stock valued at $1,153,000 after buying an additional 71,340 shares in the last quarter. Marex Group plc purchased a new stake in shares of Arteris in the second quarter valued at approximately $395,000. State of Wyoming purchased a new stake in shares of Arteris in the second quarter valued at approximately $455,000. Bank of America Corp DE increased its position in shares of Arteris by 11.8% in the second quarter. Bank of America Corp DE now owns 57,093 shares of the company's stock valued at $544,000 after buying an additional 6,008 shares in the last quarter. Finally, Ameriprise Financial Inc. purchased a new stake in shares of Arteris in the second quarter valued at approximately $742,000. 64.36% of the stock is currently owned by hedge funds and other institutional investors.

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

See Also

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Arteris Right Now?

Before you consider Arteris, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.

While Arteris currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.